An Open-Label Extension Study of De-immunized DI-Leu16-I

Project: Research project

Project Details

Description

An Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine administered in Patients with B-cell Non-Hodgkin Lymphoma (NHL)
StatusFinished
Effective start/end date9/1/149/30/19

Funding

  • ALOPEXX ONCOLOGY LLC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.